Cargando…

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

BACKGROUND: CD300s are a group of proteins playing vital roles in immune responses. However, much is yet to be elucidated regarding the expression patterns and clinical significances of CD300s in cancers. METHODS: In this study, we comprehensively investigated CD300s in a pan‐cancer manner using mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zi‐jun, Jin, Ye, Zhang, Xin‐long, Xia, Pei‐hui, Wen, Xiang‐mei, Ma, Ji‐chun, Lin, Jiang, Qian, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844665/ https://www.ncbi.nlm.nih.gov/pubmed/35642341 http://dx.doi.org/10.1002/cam4.4905

Ejemplares similares

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
por: Xu, Zi-jun, et al.
Publicado: (2022)

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation
por: Abadir, Edward, et al.
Publicado: (2019)

HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia
por: Spreafico, Marco, et al.
Publicado: (2020)

p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
por: Man, Na, et al.
Publicado: (2021)

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2019)

Association Analyses of TP53 Mutation With Prognosis, Tumor Mutational Burden, and Immunological Features in Acute Myeloid Leukemia
por: Wen, Xiang-mei, et al.
Publicado: (2021)

C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
por: Yusenko, Maria V., et al.
Publicado: (2021)

HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target
por: Liu, Lulu, et al.
Publicado: (2020)

Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia
por: Lin, Mei-si, et al.
Publicado: (2022)

CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemia
por: Sun, Xiaogang, et al.
Publicado: (2018)

Emerging role of CD300 receptors in regulating myeloid cell efferocytosis
por: Voss, Oliver H, et al.
Publicado: (2015)

Adhesion molecules in acute myeloid leukemia()
por: Paietta, Elisabeth
Publicado: (1996)

CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia
por: Yakymiv, Yuliya, et al.
Publicado: (2019)

SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia
por: Gu, Yu, et al.
Publicado: (2022)

P659: BUPARLISIB A PROMISING THERAPEUTIC APPROACH IN CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB
por: Alves, Raquel, et al.
Publicado: (2023)

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022)

Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
por: Wang, Shi-sen, et al.
Publicado: (2021)

Examination of CD302 as a potential therapeutic target for acute myeloid leukemia
por: Lo, Tsun-Ho, et al.
Publicado: (2019)

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia
por: Zhong, Fang-Min, et al.
Publicado: (2023)

Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression
por: Liu, Lulu, et al.
Publicado: (2023)

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
por: Rao, Jia, et al.
Publicado: (2011)

CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia
por: Kaito, Yuta, et al.
Publicado: (2022)

ALOX5AP is a new prognostic indicator in acute myeloid leukemia
por: Chen, Xin-Yi, et al.
Publicado: (2023)

Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia
por: Zhang, Ling‐yi, et al.
Publicado: (2021)

Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia
por: Lang, Tonio Johannes Lukas, et al.
Publicado: (2023)

SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2019)

Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
por: Xu, Zi-jun, et al.
Publicado: (2019)

Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes
por: Tapela, Neo, et al.
Publicado: (2016)

Quizartinib (AC220): a promising option for acute myeloid leukemia
por: Zhou, Fang, et al.
Publicado: (2019)

MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
por: de Araújo, Helena Varela, et al.
Publicado: (2022)

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
por: Laverdière, Isabelle, et al.
Publicado: (2018)

H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2018)

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia
por: Czardybon, Wojciech, et al.
Publicado: (2018)

Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia
por: Sun, Haibo, et al.
Publicado: (2016)

CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm
por: Pelosi, Elvira, et al.
Publicado: (2023)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
por: Barbosa, Karina, et al.
Publicado: (2023)

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia
por: Riether, Carsten, et al.
Publicado: (2017)

Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic
por: Jamrozy, Dorota M., et al.
Publicado: (2016)

BCL2 overexpression: clinical implication and biological insights in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2019)

Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia
por: Takam Kamga, Paul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lj1njnap8l85crru5c9f07kjop